A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants

NCT03952507 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-64417184 600 (Oral Tablet Formulation)
DRUG: JNJ-64417184 (Oral Suspension Formulation)

Sponsor

Janssen Research & Development, LLC